Clinical Trial Update: A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants [Phase 3]

View source ↗

Summary

A clinical trial update indicating completion of a Phase 3 study evaluating the efficacy and safety of TNM001 in high-risk infants with Respiratory Syncytial Vi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• TNM001

Snippet

Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: COMPLETED